secwatch.observer — SEC 8-K summary
======================================

Issuer:     Emergent BioSolutions Inc. (EBS)
CIK:        0001367644
Form:       8-K
Filed at:   2026-04-30T23:59:59+00:00
Accession:  0001367644-26-000051
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shareholders approve increase in Emergent BioSolutions' stock incentive plan by 5M shares
--------------------------------------------------------------------------------

- Shareholders approved amendment to stock incentive plan adding 5M shares, total reserve now 36,208,561 shares.
- Director nominees elected: Dayal, Fowler, Harsanyi, Papa; each received >93% of votes cast (excluding broker non-votes).
- Advisory say-on-pay approved with 58.4% support; 18.2M for, 12.0M against, 0.9M abstain.
- Ratification of Ernst & Young as auditor approved with 96.7% of votes cast.
- Plan amendment changes full-value award counting ratio to 1.0 from 1.6 per share for grants after April 29, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367644/000136764426000051/0001367644-26-000051-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367644/000136764426000051/ebs-20260429.htm
  HTML page:      https://secwatch.observer/filing/0001367644-26-000051

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer